Title: Application of apixaban in stroke prevention in patients with atrial fibrillation
Abstract: Atrial fibrillation (AF) is an independent risk factors for stroke. The stroke outcome in patients with AF is poor. The mortality and morbidity were also higher. As for the higher risk of stroke in patients with AF, the application of anticoagulant drugs is needed. Apixaban is an emerging oral direct X a factor inhibitor in recent years. Compared to the traditional anticoagulants, such as warfarin, apixaban shows certain advantages in the prevention of stroke and systemic embolism in patients with AF.
Key words:
Atrial Fibrillation; Stroke; Anticoagulants; Factor Xa; Apixaban; Warfarin
Publication Year: 2012
Publication Date: 2012-07-15
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot